Megaco Ophthalmology-B (06622): Signed a distribution and supply agreement with PT. ERELA for the commercialization of ciclosporin eye gel in Indonesia.

The Zhaoke Finance and Economics APP News reports that MedSci Eye Care-B (06622) has announced that the company has entered into a distribution and supply agreement with PT. Erlangga Edi Laboratories (PT.Erela), a reputable and long-established pharmaceutical company in Indonesia, for the commercialization of cyclosporine ophthalmic gel (an innovative drug for the treatment of moderate to severe dry eye syndrome) in Indonesia.